Download the Press Release (PDF)

CHICAGO, Illinois – 21 July, 2022 – Abstracts presented at the International Society for Heart and Lung Transplantation Annual Meeting gathers the latest research from around the world on caring for and improving outcomes for patients with advanced heart and lung disease. The 2022 ISHLT Annual Meeting featured more than 1,500 oral and poster presentations, integrating the 10 professional specialties represented within ISHLT – a collaborative approach that presents the best of how a multidisciplinary team cares for a patient. Each year, ISHLT recognizes the best research being presented at the meeting, highlighting investigators in each of the ISHLT Professional Communities, as well as several awards that focus on early career investigators.

The Philip K. Caves Award, Early Career Scientist Award, and Early Career Clinical Case Dilemmas Best Presentation Award encourage and reward original high-quality research from trainees, residents, fellows, graduate students, and young researchers in fields across advanced heart and lung disease and transplantation.

The ISHLT Professional Community Awards for Excellence recognize the interdisciplinary contributions made across the care continuum by ISHLT members, encouraging investigation and professional excellence in a wide variety of specialties.

These highly scored abstracts are available in a special supplement to The Journal of Heart and Lung Transplantation’s April 2022 issue.
 

	Philip K. Caves Award Aditi Nayak, MD, MS Brigham and Women’s Hospital Boston, MA USA Presentation: Machine Learning Algorithms Identify Distinct Phenotypes of Right Heart Failure After Left Ventricular Assist Device Implant
	Early Career Scientist Award Rayoun Ramendra, BSc University Health Network Toronto, ON Canada Presentation: Donor Airway Bile Acid as a Biomarker of Aspiration and Predictor of Post Lung Transplant Outcomes
	Early Career Clinical Case Dilemmas Best Presentation Award Hyeon-Ju Ali, MD Houston Methodist Hospital Houston, TX USA Presentation: Management of Pulmonary Hypertension Secondary to Valvular Heart Disease with Angiotensin-Receptor Neprilysin Inhibitor
	Cardiology Professional Community Award for Excellence Bhavadharini Ramu, MD, FACC Medical University of South Carolina Charleston, SC USA Presentation: Sex-Based Outcomes After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device
	Cardiothoracic Surgery Professional Community Award for Excellence Justin C.Y. Chan, MD, MPhil New York University Langone Health New York, NY USA Presentation: Impact of Sex on Outcome After Pulmonary Endarterectomy (PEA) for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
	Nursing and Allied Health Professional Community Award for Excellence Sarah Schettle, PA-C, MS, MBA Mayo Clinic Rochester, MN USA Presentation: Does Hemoglobin A1c Accurately Depict Diabetic Control in LVAD Patients?
	Pediatrics Professional Community Award for Excellence Lydia K. Wright, MD, MSc Nationwide Children’s Hospital Columbus, OH USA Presentation: Status Exceptions and Racial Disparities in Pediatric Heart Transplant Waitlist Outcomes
	Pulmonology Professional Community Award for Excellence Sean Agbor-Enoh, MD, PhD National Heart, Lung, and Blood Institute Johns Hopkins University School of Medicine Bethesda, MD USA Presentation: Is Acute Rejection Truly Acute or an Exacerbation of an Underlying Disease?
	Research and Immunology Professional Community Award for Excellence Daniel R. Calabrese, MD University of California, San Francisco San Francisco, CA USA Presentation: Bronchoalveolar Lavage MICB is Associated with Severe Primary Graft Dysfunction, Prolonged Mechanical Ventilation, and Low Post-Transplant FEV1 in Lung Transplant Recipients

 
About ISHLT
The International Society for Heart and Lung Transplantation is a not-for-profit, multidisciplinary professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies. With more than 3,800 members in more than 45 countries, ISHLT is the world’s largest organization dedicated to the research, education and advocacy of end-stage heart and lung disease. ISHLT members represent more than 15 different professional disciplines. For more information, visit www.ishlt.org.